Last reviewed · How we verify
NCT05517005
An Exploratory Investigation of a B12 Vitamin to Increase Energy and Focus
NA trial testing Hype Bites Supplement in B12 Deficiency Vitamin in 38 participants. Completed in 30 September 2022.
30 September 2022
Quick facts
| Lead sponsor | Sourse |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | other |
| Enrollment | 38 |
| Start date | 22 May 2022 |
| Primary completion | 30 September 2022 |
| Estimated completion | 30 September 2022 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Hype Bites Supplement
Conditions studied
- B12 Deficiency Vitamin — all drugs for B12 Deficiency Vitamin →
- Energy Supply; Deficiency — all drugs for Energy Supply; Deficiency →
- Mood — all drugs for Mood →
Sponsor
Sourse
Who can join
Adults 24 to 65, any sex, with B12 Deficiency Vitamin or Energy Supply; Deficiency. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to examine the effects of Sourse's Hype Bites at being able to increase vitamin B12 levels to promote positive health outcomes. Participants will consume Hype Bites daily. Participants will also take surveys and blood samples to examine both the subjective experience of taking Hype Bites as well as changes in biomarkers across the trial.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05517005
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for B12 Deficiency Vitamin
Currently open trials in the same condition.
- NCT05714917 — Neurological Recovery Following NOS-SACD · recruiting
- NCT04694235 — Egg Intervention During Pregnancy in Indonesia · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05517005 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Sourse
- Last refreshed: 23 August 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05517005.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing